Use my Search Websuite to scan PubMed, PMCentral, Journal Hosts and Journal Archives, FullText. Kick-your-searchterm to multiple Engines kick-your-query now !>

A dictionary by aggregated review articles of nephrology, medicine and the life sciences Your one-stop-run pathway from word to the immediate pdf of peer-reviewed on-topic knowledge.

10.1136/bcr-2021-244168 http://scihub22266oqcxt.onion/10.1136/bcr-2021-244168 34446515!8395362!34446515     free     free     free Deprecated: Implicit conversion from float 211.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534       BMJ+Case+Rep 2021 ; 14 (8): ä Nephropedia Template TP {{tp|p=34446515|t=2021. Liver transplantation for post-COVID-19 sclerosing cholangitis |pdf=|usr=}}{{34446515}} gab.com Text Liver transplantation for post-COVID-19 sclerosing cholangitis JO: BMJ Case Rep http://www.kidney.de/pget.php?&tw=1&pmid=34446515 #FOAvip Since identified in December 2019, COVID-19 has remained a pandemic across the globe. Although primarily a respiratory illness, the impact of COVID-19 on other end organs has been increasingly identified. The effect of COVID-19 on the liver has yet to be completely understood. We describe a case of COVID-19 leading to end-stage cholangiopathy and deceased donor liver transplantation (LT). A 64-year-old man with no underlying respiratory or liver disease presented with acute respiratory distress secondary to COVID-19 pneumonia requiring intubation. Several months after resolution of his respiratory symptoms, he developed transaminitis, worsening jaundice, abdominal pain and dark-coloured urine. Hepatic function remained severely impaired warranting LT 259 days following his initial COVID-19 diagnosis. Explant pathology demonstrated diffuse hepatic injury, onion skinning of the bile ducts and bile duct loss in scattered portal tracts. As more patients develop COVID-19-related complications, we suggest LT as an option for COVID-19-related end-stage liver disease. Twit Text FOAVip Liver transplantation for post-COVID-19 sclerosing cholangitis ????BMJ Case Rep http://www.kidney.de/pget.php?&tw=1&pmid=34446515 #FOAvip Twit Text # Free Paper on # # # # # LINK http://www.kidney.de/pget.php?&tw=1&pmid=34446515 #FOAvip English Wikipedia <ref>{{Cite pmid|34446515}}</ref> Liver transplantation for post-COVID-19 sclerosing cholangitis #MMPMID34446515 Lee A; Wein AN; Doyle MBM; Chapman WC BMJ Case Rep 2021[Aug]; 14 (8): ä PMID34446515show ga Since identified in December 2019, COVID-19 has remained a pandemic across the globe. Although primarily a respiratory illness, the impact of COVID-19 on other end organs has been increasingly identified. The effect of COVID-19 on the liver has yet to be completely understood. We describe a case of COVID-19 leading to end-stage cholangiopathy and deceased donor liver transplantation (LT). A 64-year-old man with no underlying respiratory or liver disease presented with acute respiratory distress secondary to COVID-19 pneumonia requiring intubation. Several months after resolution of his respiratory symptoms, he developed transaminitis, worsening jaundice, abdominal pain and dark-coloured urine. Hepatic function remained severely impaired warranting LT 259 days following his initial COVID-19 diagnosis. Explant pathology demonstrated diffuse hepatic injury, onion skinning of the bile ducts and bile duct loss in scattered portal tracts. As more patients develop COVID-19-related complications, we suggest LT as an option for COVID-19-related end-stage liver disease. |*COVID-19[MESH] |*Cholangitis, Sclerosing/complications/surgery[MESH] |*Liver Transplantation[MESH] |COVID-19 Testing[MESH] |Humans[MESH] |Living Donors[MESH] |Male[MESH] |Middle Aged[MESH]Liver transplantation for post-COVID-19 sclerosing cholangitis (epmc).pdf DeepDyve Pubget Overpricing